Exciting Opportunities for Exhibitors at the 2014 NJ Symposium on Biomaterials Science

Share Article

Exhibitors from companies engaged with producing bioactive materials for regenerative medicine can reach leading researchers and product developers at the NJ Center for Biomaterials 12th New Jersey Symposium - Bioactive Scaffolds: From Synthetic Polymers to ECM and Decellularized Tissues, scheduled for October 6-7, 2014 at the Heldrich Hotel, New Brunswick, NJ.

The audience for biomaterials research is exploding. New developments in biomaterials and their impact on regenerative medicine have become headline news. No other event in the region provides a better venue for industry to reach molecular biologists, immunologists, pharmaceutical scientists, tissue engineers and regenerative medicine clinicians than the 12th edition of the New Jersey Symposium on Biomaterials Science. This event creates a unique opportunity for companies to present their products to an elite assembly of chemists, biologists, and biomedical engineers who are at the forefront of developments in regenerative medicine.

The 2014 NJ Symposium on Biomaterials Science will once again attract several hundred leaders in biomaterials research and feature a roster of presentations by more than 30 leading scientists, many with global reputations for their work in academia and industry in the areas of biomaterials, bioengineering and clinical practice. Held every other year, the NJ Symposium on Biomaterials Science, has been a premier venue for companies that seek to interact with these scientists. Detailed information about the symposium, opportunities for exhibitors and registration links will be found at http://www.njbiomaterials.org/biomaterials-symposia.htm

The New Jersey Center for Biomaterials (NJCBM) was founded by Joachim Kohn, PhD. in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Bushby
Visit website